These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25712190)

  • 1. In vitro human cell line models to predict clinical response to anticancer drugs.
    Niu N; Wang L
    Pharmacogenomics; 2015; 16(3):273-85. PubMed ID: 25712190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
    Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines.
    Niu N; Liu T; Cairns J; Ly RC; Tan X; Deng M; Fridley BL; Kalari KR; Abo RP; Jenkins G; Batzler A; Carlson EE; Barman P; Moran S; Heyn H; Esteller M; Wang L
    Hum Mol Genet; 2016 Nov; 25(21):4819-4834. PubMed ID: 28173075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
    Loomis R; Carbone R; Reiss M; Lacy J
    Clin Cancer Res; 2003 May; 9(5):1931-9. PubMed ID: 12738752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
    Huang S; Hu P; Lakowski TM
    BMC Cancer; 2021 May; 21(1):648. PubMed ID: 34059012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics.
    Goodspeed A; Heiser LM; Gray JW; Costello JC
    Mol Cancer Res; 2016 Jan; 14(1):3-13. PubMed ID: 26248648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies.
    Shukla SJ; Dolan ME
    Pharmacogenomics; 2005 Apr; 6(3):303-10. PubMed ID: 16013961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay.
    Griffiths M; Sundaram H
    Methods Mol Biol; 2011; 731():451-65. PubMed ID: 21516428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miniaturized three-dimensional cancer model for drug evaluation.
    Lovitt CJ; Shelper TB; Avery VM
    Assay Drug Dev Technol; 2013 Sep; 11(7):435-48. PubMed ID: 25310845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
    Kong D; Yamori T
    Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read-outs.
    Santo VE; Rebelo SP; Estrada MF; Alves PM; Boghaert E; Brito C
    Biotechnol J; 2017 Jan; 12(1):. PubMed ID: 27966285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI-60 panel.
    Le Morvan V; Bellott R; Moisan F; Mathoulin-Pélissier S; Bonnet J; Robert J
    Pharmacogenomics; 2006 Sep; 7(6):843-52. PubMed ID: 16981845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
    Prestwich GD
    Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing.
    Podolski-Renić A; Jadranin M; Stanković T; Banković J; Stojković S; Chiourea M; Aljančić I; Vajs V; Tešević V; Ruždijić S; Gagos S; Tanić N; Pešić M
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):683-97. PubMed ID: 23934261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiologically relevant in vitro tumor models for drug screening.
    Das V; Bruzzese F; Konečný P; Iannelli F; Budillon A; Hajdúch M
    Drug Discov Today; 2015 Jul; 20(7):848-55. PubMed ID: 25908576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway Activation.
    Singh M; Close DA; Mukundan S; Johnston PA; Sant S
    Assay Drug Dev Technol; 2015 Nov; 13(9):570-83. PubMed ID: 26274587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of gene polymorphisms of the folate pathway enzymes in gene expression and anticancer drug sensitivity using the NCI-60 panel as a model.
    Charasson V; Hillaire-Buys D; Solassol I; Laurand-Quancard A; Pinguet F; Le Morvan V; Robert J
    Eur J Cancer; 2009 Sep; 45(13):2391-401. PubMed ID: 19501504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered 3D environments to elucidate the effect of environmental parameters on drug response in cancer.
    Håkanson M; Textor M; Charnley M
    Integr Biol (Camb); 2011 Jan; 3(1):31-8. PubMed ID: 21049126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination effects of SC144 and cytotoxic anticancer agents.
    Oshima T; Cao X; Grande F; Yamada R; Garofalo A; Louie S; Neamati N
    Anticancer Drugs; 2009 Jun; 20(5):312-20. PubMed ID: 19322070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.